237 related articles for article (PubMed ID: 29706107)
1. Adaptive radiotherapy in head and neck cancer is required to avoid tumor underdose.
Castelli J; Simon A; Rigaud B; Chajon E; Thariat J; Benezery K; Vauleon E; Jegoux F; Henry O; Lafond C; de Crevoisier R
Acta Oncol; 2018 Sep; 57(9):1267-1270. PubMed ID: 29706107
[No Abstract] [Full Text] [Related]
2. MRI-guided radiotherapy for head and neck cancer: initial clinical experience.
Chen AM; Hsu S; Lamb J; Yang Y; Agazaryan N; Steinberg ML; Low DA; Cao M
Clin Transl Oncol; 2018 Feb; 20(2):160-168. PubMed ID: 28612199
[TBL] [Abstract][Full Text] [Related]
3. RapidArc planning and delivery in patients with locally advanced head-and-neck cancer undergoing chemoradiotherapy.
Doornaert P; Verbakel WF; Bieker M; Slotman BJ; Senan S
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):429-35. PubMed ID: 20421159
[TBL] [Abstract][Full Text] [Related]
4. Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial.
Schwartz DL; Garden AS; Thomas J; Chen Y; Zhang Y; Lewin J; Chambers MS; Dong L
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):986-93. PubMed ID: 22138459
[TBL] [Abstract][Full Text] [Related]
5. End of treatment cone-beam computed tomography (CBCT) is predictive of radiation response and overall survival in oropharyngeal squamous cell carcinoma.
Sumner W; Kim SS; Vitzthum L; Moore K; Atwood T; Murphy J; Miyauchi S; Califano JA; Mell LK; Mundt AJ; Sharabi AB
Radiat Oncol; 2021 Aug; 16(1):147. PubMed ID: 34372887
[TBL] [Abstract][Full Text] [Related]
6. Radiation Oncology--New Approaches in Squamous Cell Cancer of the Head and Neck.
Margalit DN; Schoenfeld JD; Tishler RB
Hematol Oncol Clin North Am; 2015 Dec; 29(6):1093-106. PubMed ID: 26568550
[TBL] [Abstract][Full Text] [Related]
7. Adaptive planning in intensity-modulated radiation therapy for head and neck cancers: single-institution experience and clinical implications.
Ahn PH; Chen CC; Ahn AI; Hong L; Scripes PG; Shen J; Lee CC; Miller E; Kalnicki S; Garg MK
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):677-85. PubMed ID: 20619553
[TBL] [Abstract][Full Text] [Related]
8. Data-driven approach to generating achievable dose-volume histogram objectives in intensity-modulated radiotherapy planning.
Wu B; Ricchetti F; Sanguineti G; Kazhdan M; Simari P; Jacques R; Taylor R; McNutt T
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1241-7. PubMed ID: 20800382
[TBL] [Abstract][Full Text] [Related]
9. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer.
Chen AM; Farwell DG; Luu Q; Chen LM; Vijayakumar S; Purdy JA
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1423-9. PubMed ID: 20656416
[TBL] [Abstract][Full Text] [Related]
10. [Radiation therapy to the head and neck. IMRT and IGRT do a paradigm shift].
Ariji T
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2013 Nov; 69(11):1306-12. PubMed ID: 24256656
[No Abstract] [Full Text] [Related]
11. Adaptive radiotherapy for head and neck cancer: Are we ready to put it into routine clinical practice?
Gensheimer MF; Le QT
Oral Oncol; 2018 Nov; 86():19-24. PubMed ID: 30409300
[TBL] [Abstract][Full Text] [Related]
12. Head and Neck Margin Reduction With Adaptive Radiation Therapy: Robustness of Treatment Plans Against Anatomy Changes.
van Kranen S; Hamming-Vrieze O; Wolf A; Damen E; van Herk M; Sonke JJ
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):653-60. PubMed ID: 27681762
[TBL] [Abstract][Full Text] [Related]
13. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma.
Dirix P; Nuyts S
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1373-80. PubMed ID: 20362402
[TBL] [Abstract][Full Text] [Related]
14. Computed tomography number changes observed during computed tomography-guided radiation therapy for head and neck cancer.
Feng M; Yang C; Chen X; Xu S; Moraru I; Lang J; Schultz C; Li XA
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1041-7. PubMed ID: 25832695
[TBL] [Abstract][Full Text] [Related]
15. Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma.
Mendenhall WM; Amdur RJ; Morris CG; Kirwan JM; Li JG
Laryngoscope; 2010 Nov; 120(11):2218-22. PubMed ID: 20938964
[TBL] [Abstract][Full Text] [Related]
16. Patterns of Recurrence in Electively Irradiated Lymph Node Regions After Definitive Accelerated Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
van den Bosch S; Dijkema T; Verhoef LC; Zwijnenburg EM; Janssens GO; Kaanders JH
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):766-74. PubMed ID: 26972649
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers.
Bhide SA; Newbold KL; Harrington KJ; Nutting CM
Br J Radiol; 2012 May; 85(1013):487-94. PubMed ID: 22556403
[TBL] [Abstract][Full Text] [Related]
18. Daily kV cone-beam CT and deformable image registration as a method for studying dosimetric consequences of anatomic changes in adaptive IMRT of head and neck cancer.
Elstrøm UV; Wysocka BA; Muren LP; Petersen JB; Grau C
Acta Oncol; 2010 Oct; 49(7):1101-8. PubMed ID: 20831502
[TBL] [Abstract][Full Text] [Related]
19. Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life.
Spencer CR; Gay HA; Haughey BH; Nussenbaum B; Adkins DR; Wildes TM; DeWees TA; Lewis JS; Thorstad WL
Cancer; 2014 Dec; 120(24):3994-4002. PubMed ID: 25143048
[TBL] [Abstract][Full Text] [Related]
20. Initial clinical experience with helical tomotherapy for head and neck cancer.
Chen AM; Jennelle RL; Sreeraman R; Yang CC; Liu T; Vijayakumar S; Purdy JA
Head Neck; 2009 Dec; 31(12):1571-8. PubMed ID: 19405087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
